| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abortion on the Supreme Court Agenda: Planned Parenthood v. Casey and its Possible Consequences
|
Koslov, Tara Isa
|
|
1992
|
20 |
3 |
p. 243-248
|
artikel
|
| 2 |
Acceptability of Mifepristone for Early Pregnancy Interruption
|
David, Henry P.
|
|
1992
|
20 |
3 |
p. 188-194
|
artikel
|
| 3 |
Antiprogestin Drugs: Ethical Issues
|
Macklin, Ruth
|
|
1992
|
20 |
3 |
p. 215-219
|
artikel
|
| 4 |
Antiprogestin Drugs: Ethical, Legal and Medical Issues
|
Cook, Rebecca J.
|
|
1992
|
20 |
3 |
p. 149-153
|
artikel
|
| 5 |
Antiprogestin Drugs: Research and Clinical Use in Sweden
|
Bygdeman, Marc
|
|
1992
|
20 |
3 |
p. 157-160
|
artikel
|
| 6 |
Are Adolescents Good Candidates for RU 486 as an Abortion Method?
|
Senderowitz, Judith
|
|
1992
|
20 |
3 |
p. 209-214
|
artikel
|
| 7 |
Benten v. Kessler: The RU 486 Import Case
|
Pine, Rachael N.
|
|
1992
|
20 |
3 |
p. 238-242
|
artikel
|
| 8 |
Capping the Crisis: Medical Malpractice and Tort Reform
|
Javitt, Gail
|
|
1992
|
20 |
3 |
p. 258-261
|
artikel
|
| 9 |
Do Pharmacists Have a Right to Refuse to Fill Prescriptions for Abortifacient Drugs?
|
Weinstein, Bruce D.
|
|
1992
|
20 |
3 |
p. 220-223
|
artikel
|
| 10 |
“Inducing a Miscarriage”: Women-Centered Perspectives on RU 486/Prostaglandin as an Early Abortion Method
|
Berer, Marge
|
|
1992
|
20 |
3 |
p. 199-208
|
artikel
|
| 11 |
Introduction of Abortion Technologies: A Quality of Care Management Approach
|
Greenslade, Forrest C.
|
|
1992
|
20 |
3 |
p. 161-168
|
artikel
|
| 12 |
Medical Uncertainty (Reprise)
|
Merz, Jon F.
|
|
1992
|
20 |
3 |
p. 268-270
|
artikel
|
| 13 |
Other Recent Case Developments
|
|
|
1992
|
20 |
3 |
p. 262-267
|
artikel
|
| 14 |
Patents and the Supply of Therapeutic Products
|
Hayhurst, William L.
|
|
1992
|
20 |
3 |
p. 235-237
|
artikel
|
| 15 |
Patient Dumping in the Federal Courts: Expanding EMTALA without Preempting State Malpractice Law
|
Jain, Samir C.
|
|
1992
|
20 |
3 |
p. 249-252
|
artikel
|
| 16 |
RU 486 in France and England: Corporate Ethics and Compulsory Licensing
|
Boland, Reed
|
|
1992
|
20 |
3 |
p. 226-234
|
artikel
|
| 17 |
RU 486/Prostaglandin: Considerations for Appropriate Use in Low-Resource Settings
|
Holt, Renee
|
|
1992
|
20 |
3 |
p. 169-183
|
artikel
|
| 18 |
RU 486, the FDA and Free Enterprise
|
Buc, Nancy L.
|
|
1992
|
20 |
3 |
p. 224-225
|
artikel
|
| 19 |
RU 486: What Physicians Know, Think and (Might) Do—A Survey of California Obstetrician/Gynecologists
|
Heilig, Steve L.
|
|
1992
|
20 |
3 |
p. 184-187
|
artikel
|
| 20 |
Studying the Acceptability and Feasibility of Medical Abortion
|
Winikoff, Beverly
|
|
1992
|
20 |
3 |
p. 195-198
|
artikel
|
| 21 |
The FDA: Is it Protecting the Public with One Hand Tied behind its Back?
|
Shedlin, Roger S.
|
|
1992
|
20 |
3 |
p. 253-257
|
artikel
|
| 22 |
Updating RU 486 Development
|
Baulieu, Etienne-Emile
|
|
1992
|
20 |
3 |
p. 154-156
|
artikel
|
Tijdschrift beschrijving